SCHEMBL6977646

SCHEMBL6977646

O=C(c1ccccn1)N1CCC(CNCC2COc3ccc(Cl)cc3O2)CC1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 12/20 0.58
ADRA1A P35348 12/20 0.58
ADRA1B P35368 12/20 0.58
HTR1A P08908 1/20 0.58
DRD2 P14416 1/20 0.58
DRD4 P21917 1/20 0.58
HTR2C P28335 1/20 0.58
DRD3 P35462 1/20 0.58
EPHX1 P07099 1/20 0.46
EPHX2 P34913 1/20 0.46
NPY5R Q15761 1/20 0.45
CA2 P00918 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970869 0.86 ADRA1D (0.54) ADRA1DADRA1AADRA1BHTR1ADRD2
Alcohol SCHEMBL8547581 0.84 ADRA1D (0.56) ADRA1DADRA1AADRA1BHTR1ADRD2
Alcohol SCHEMBL8381334 0.84 ADRA1D (0.56) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL8096185 0.82 ADRA1D (0.58) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL8096179 0.82 ADRA1D (0.58) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL8384932 0.81 ADRA1D (0.55) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL6980379 0.81 ADRA1D (0.55) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL7469835 0.79 ADRA1D (0.47) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL9302003 0.79 ADRA1D (0.60) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL6763070 0.76 ADRA1D (0.76) ADRA1DADRA1AADRA1BHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP claimed
CN-1071755-C Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 2001-09-26 CN claimed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US claimed
CN-1190967-A Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 1998-08-19 CN claimed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP claimed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO claimed
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
CN-1071755-C Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 2001-09-26 CN disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
CN-1190967-A Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 1998-08-19 CN disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed